epirubicin has been researched along with Hepatitis B, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, R; Dong, Y; Fan, H; Gu, J; Jia, Y; Li, Y; Liu, C; Ma, X; Miao, R; Niu, W; Qu, K; Ren, L; Wang, H; Wang, Z; Zhang, J; Zhang, X | 1 |
| Lao, XM; Li, SP; Lin, XJ; Shi, M | 1 |
| Igarashi, Y; Kanayama, M; Matsui, T; Momiyama, K; Nagai, H; Sumino, Y; Wakui, N; Watanabe, M | 1 |
| Chen, SH; Chuang, WL; Hsieh, MY; Huang, CF; Lin, CI; Lin, ZY | 1 |
| Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Chung, KW; Jang, JW; Kim, CW; Lee, CD; Lee, YS; Sun, HS; Yang, JM; Yoon, SK | 1 |
| Hirashita, T; Nakashima, K; Sakai, I; Sakai, M | 1 |
1 review(s) available for epirubicin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; DNA, Viral; Doxorubicin; Epirubicin; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Rituximab; Virus Activation | 2016 |
2 trial(s) available for epirubicin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; DNA, Viral; Epirubicin; Female; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Mitomycin; Odds Ratio; Risk Factors; RNA, Viral; ROC Curve; Viral Load; Virus Activation; Virus Replication | 2011 |
Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Recurrence; Retrospective Studies; Virus Activation | 2004 |
3 other study(ies) available for epirubicin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization.
Topics: Alanine Transaminase; Alkaline Phosphatase; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Camptothecin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Female; Fluorouracil; gamma-Glutamyltransferase; Hepatectomy; Hepatitis B, Chronic; Humans; Hypertension, Portal; Leukocyte Count; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Monocytes; Neoplasm Staging; Neutrophils; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tumor Burden | 2019 |
Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Ethiodized Oil; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Infusions, Intra-Arterial; Japan; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Male; Prognosis | 2011 |
[Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Hepatitis B, Chronic; Humans; Infusions, Intra-Arterial; Liver Cirrhosis; Liver Neoplasms; Male; Remission Induction | 2007 |